Rethinking pharmacy conversations on asthma care
Pharmacy interventions in asthma management can be difficult because patients often don’t understand the underlying nature of the condition.
Behind the obsessions: a guide to obsessive-compulsive disorder
Obsessive-compulsive disorder is best managed with cognitive behavioural therapy, SSRIs and ongoing pharmacist support.
Sunscreen reassurance on nanotoxicity fears
Nanoparticles contained in sunscreen do not penetrate the skin or cause cellular toxicity, a new Australian study published in the Journal of Investigative Dermatology...
Don’t forget about tuberculosis
TB is an infectious disease that has massive mortality globally; however, due to public health initiatives is mostly eradicated in Australia. Despite this, cases can still occur, and pharmacists should be aware of TB and its recommended treatment to ensure appropriate management.
Preventing harm: medicine safety in children
Medicine safety in children requires vigilance, clear communication and proactive intervention by pharmacists to prevent accidental poisonings.
TGA seeks input on benzocaine advisory statements
The Therapeutic Goods Administration (TGA) has requested comments from interested parties on the addition of a new advisory statement for labels of non-prescription medicines...













